Abstract:You have accessJournal of UrologyKidney Cancer: Basic Research & Pathophysiology II1 Apr 2017MP60-13 LOSS OF FAT MASS AND OBESITY ASSOCIATED GENE (FTO) DECREASES PROLIFERATION AND INVASION IN RENAL CELL CARCINOMA CELL-LINE BY UPREGULATION OF NF-KAPPA B SIGNALING PATHWAY Hongkai Wang, JunLong Wu, HaiLiang Zhang, GuoHai Shi, Yao Zhu, and DingWei Ye Hongkai WangHongkai Wang More articles by this author , JunLong WuJunLong Wu More articles by this author , HaiLiang ZhangHaiLiang Zhang More articles by this author , GuoHai ShiGuoHai Shi More articles by this author , Yao ZhuYao Zhu More articles by this author , and DingWei YeDingWei Ye More articles by this author View All Author Informationhttps://doi.org/10.1016/j.juro.2017.02.1850AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookTwitterLinked InEmail INTRODUCTION AND OBJECTIVES FTO was the first GWAS identified gene which was associated with obesity, considering the interaction between obesity and renal cell carcinoma(RCC), the biological role of FTO in RCC is of great interest. METHODS We examined the expression of the FTO gene in RCC cell lines and the effect of FTO on cell proliferation and invasion in RCC A498 and 786-O cells. Microarray processing and analysis was used to explore novel pathways involved in FTO tumorigenesis. RESULTS TO was expressed at high levels in A498 cells and low levels in 786-O cells. Lentivirus-mediated FTO knockdown in RCC A498 cells caused cell-cycle increase in the G1/S phase and dramatically inhibited proliferation and invasion in culture. By contrast, over-expression of FTO in 786-O cells increased proliferation and invasion. Pathway gene chip analysis revealed that FTO knockdown resulted in the NF-kappa B signaling pathway activation. IL-1R, TLR4, BIRC2, RIG-I were significantly upregulated after FTO knockdown. CONCLUSIONS These findings demonstrate that FTO may alter proliferation, invasion and cell cycle of renal cell carcinoma cell lines through the NF-kappa B signaling pathway. © 2017FiguresReferencesRelatedDetails Volume 197Issue 4SApril 2017Page: e795 Advertisement Copyright & Permissions© 2017MetricsAuthor Information Hongkai Wang More articles by this author JunLong Wu More articles by this author HaiLiang Zhang More articles by this author GuoHai Shi More articles by this author Yao Zhu More articles by this author DingWei Ye More articles by this author Expand All Advertisement Advertisement PDF downloadLoading ...

FTO interacts with FOXO3a to enhance its transcriptional activity and inhibits aggression in gliomas

SPI1-induced Downregulation of FTO Promotes GBM Progression by Regulating Pri-Mir-10a Processing in an M6a-Dependent Manner

FTO Inhibition Enhances the Antitumor Effect of Temozolomide by Targeting MYC-miR-155/23a Cluster-MXI1 Feedback Circuit in Glioma

Studies on the fat mass and obesity-associated (FTO) gene and its impact on obesity-associated diseases

Fat mass and obesity-associated (FTO) protein regulates adult neurogenesis.

FOXO4 Expression Associates with Glioblastoma Development and FOXO4 Expression Inhibits Cell Malignant Phenotypes in Vitro and in Vivo.

FTO promotes proliferation and migration of bladder cancer via enhancing stability of STAT3 mRNA in an m6A-dependent manner

Targeting FTO Suppresses Cancer Stem Cell Maintenance and Immune Evasion

FTO downregulation mediated by hypoxia facilitates colorectal cancer metastasis

Fat mass and obesity associated (FTO)-mediated N6-methyladenosine modification of Krüppel-like factor 3 (KLF3) promotes osteosarcoma progression

FTO modifies the m6A level of MALAT and promotes bladder cancer progression

FTO Sensitizes Oral Squamous Cell Carcinoma to Ferroptosis via Suppressing ACSL3 and GPX4

Fat mass and obesity-associated protein (FTO) mediated m6A modification of circFAM192A promoted gastric cancer proliferation by suppressing SLC7A5 decay

Targeting fat mass and obesity-associated protein mitigates human colorectal cancer growth in vitro and in a murine model

Tumors exploit FTO-mediated regulation of glycolytic metabolism to evade immune surveillance

Targeting FTO induces colorectal cancer ferroptotic cell death by decreasing SLC7A11/GPX4 expression

MP60-13 LOSS OF FAT MASS AND OBESITY ASSOCIATED GENE (FTO) DECREASES PROLIFERATION AND INVASION IN RENAL CELL CARCINOMA CELL-LINE BY UPREGULATION OF NF-KAPPA B SIGNALING PATHWAY

Demethyltransferase FTO alpha-ketoglutarate dependent dioxygenase (FTO) regulates the proliferation, migration, invasion and tumor growth of prostate cancer by modulating the expression of melanocortin 4 receptor (MC4R)

Targeting FTO suppresses hepatocellular carcinoma by inhibiting ERBB3 and TUBB4A expression

The Fat Mass and Obesity Associated Gene Fto Functions in the Brain to Regulate Postnatal Growth in Mice

FTO promotes cell proliferation and migration in esophageal squamous cell carcinoma through up-regulation of MMP13.